4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-003835
Chief Financial Officer sold 50,000 shares at an average $63.41 ($3,170,268)
- Chief Financial Officer acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Chad M · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-13 | Exercise or conversion : show line 1 in the form | +50,000 | $6.32 | $316,000 | 51,000 | D |
| 2021-01-13 | Sale : show line 2 in the form | −15,820 | $62.92 | $995,394 | 35,180 | D |
| 2021-01-13 | Sale : show line 3 in the form | −34,180 | $63.63 | $2,174,873 | 1,000 | D |
| Open-market sales · 50,000 sh · avg $63.41 · $3,170,268 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-13 | Exercise or conversion : show line 4 in the form Stock Option (Right To Buy) | −50,000 | 365,000 | D |
Loading xslF345X03/doc4.xml…